RT @StefanKertesz: 5/From the frontlines I see an enormous number of new clinicians across professions who are *taking up the call* of serv…

5/From the frontlines I see an enormous number of new clinicians across professions who are *taking up the call* of service for addiction, at least in regard to buprenorphine prescribing - but we are starting from a depleted baseline https://t.co/olgktb5fO

@_jennystarfish_ @fletcha3 @davidthekick 1 Insufficient Training, Education, Experience 2 Lack of Institutional and Clinician Peer Support 3 Poor Care Coordination 4 Provider Stigma 5 Inadequate or Burdensome Reimbursement 6 Burdensome Regulatory Procedure

Myth: If you're motivated for #recovery, you'll get the necessary #treatment. #TruthDay: 72% of rural counties in the US do not have a buprenorphine-waivered physician, making OUD treatment hard to come by. 🔗: https://t.co/Vp6COg9yRL #addiction #betterli

Less than 4% of physicians could prescribe buprenorphine in 2017. This is why we recruit and train providers so patients receive the #treatment they deserve. SAMHSA Rx Waiver: https://t.co/KZNuEIB5tb 🔗: https://t.co/r9JSNhstv4 #TreatmentWeek #addiction #r

https://t.co/Alh4KAHnav @HouseDemocrats @HouseGOP @MedicalPost @medicalpolicy

.@haffajee_r @Amy_Bohnert & @PoojaLagisetty recently offered policy recommendations to address this and 5 other key barriers to buprenorphine treatment https://t.co/tQxpIXmzP3 https://t.co/L3P86Gd5wi

RT @CHWS_NY: "At least 2.3 million people in the US have an #opioid use disorder, less than 40% of whom receive evidence-based treatment."…

"At least 2.3 million people in the US have an #opioid use disorder, less than 40% of whom receive evidence-based treatment." Researchers from @umichsph explore #health workforce barriers to buprenorphine treatment and offer policy recommendations https://

Estimates vary but seems like best case scenario is that 40% of SUD patients are getting MAT https://t.co/WkEhFYFxGJ